Cite
HARVARD Citation
Van Laeken, C. et al. (2022). Clinical factors associated with early disease progression after radioembolization for hepatocellular carcinoma and feasibility of post‐progression systemic therapy. Liver Cancer International. 3 (3), pp. 128-136. [Online].